Canada Markets close in 1 hr 18 mins

XORTX Therapeutics Inc. (XRX.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
3.5800-0.1300 (-3.50%)
As of 2:34PM EDT. Market open.
Full screen
Loading interactive chart...
  • GlobeNewswire

    XORTX Therapeutics Announces Closing of US$12 Million Public Offering

    CALGARY, Alberta, Oct. 15, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX | NASDAQ: XRTX), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, today announced the closing of an underwritten public offering of 2,906,000 units ("Units"), with each Unit consisting of one common share, no par value, and one warrant ("Warrant") to purchase one common share at a public offering price of US$4.13 per

  • GlobeNewswire

    XORTX Announces Results from Mount Sinai’s COVID-19 Clinical Study

    Early, High Uric Acid is Independently Associated with Acute Kidney Injury and Mortality in COVID-19CALGARY, Alberta, Oct. 14, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX | NASDAQ: XRTX), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce and share the results of an American Society of Nephrology Kidney Week abstract by Dr. Steven Coca and team at Mount Sinai Hospit

  • GlobeNewswire

    XORTX to Present at the LD Micro Main Event

    Virtual Corporate Presentation – October 14, 2021 – 10 am ETCALGARY, Alberta, Oct. 14, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX | NASDAQ: XRTX), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, announces its participation in the LD Micro Main Event, being held October 12 through 14, 2021. Dr. Allen Davidoff stated, “LD Micro is a premier MicroCap investor conference, we are pleased t